Public trial registry of the CCC-Munich

Trial 16349 BAY 80-6946

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
16349 BAY 80-6946
World
Full title
:

Phase II PI3K inhibitor in relapsed, indolent or aggressive NHL

World
Description
:

Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in
patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C85.- Sonstige und nicht näher bezeichnete Typen des Non-Hodgkin-Lymphoms
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
World
BfArM - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
Last
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.